Tag: brokerswatch

Sep 13
Biden says CPI report shows progress in bringing down inflation, but there’s ‘more work still to do’

Published: Sept. 13, 2022 at 10: 11 a.m. ET President Joe Biden said in a statement Tuesday that the August data for consumer prices “show more progress in bringing global inflation down in the U.S. economy. Overall, prices have been essentially flat in our country these last two months: that is welcome news for American […]

Sep 13
Consumer discretionary stocks takes a broad beating after consumer inflation data

The selloff in the consumer discretionary sector was unanimous Tuesday, as disappointing inflation data sparked fears that consumers would pull back on spending as prices keep rising, and as the Federal Reserve could trigger a recession with continued aggressive interest rate increases. The SPDR Consumer Discretionary Select Sector exchange-traded fund XLY, -3.94% dropped 3.3% in […]

Sep 13
Bank stocks move into the red after inflation data

Bank stocks fell with the broad market in early trades on Monday, as Wall Street absorbed the impact of bearish Consumer Price Index data. JPMorgan Chase & Co. JPM, -3.15% fell 2.1%, Goldman Sachs Group Inc. GS, -3.58% dropped 2.2%, Citigroup Inc. C, -2.88% subtracted 2% and Wells Fargo & Co. WFC, -4.55% gave up […]

Sep 13
U.S. stocks open sharply lower, Dow drops more than 500 points after stronger-than-expected inflation

U.S. stocks opened sharply lower Tuesday as investors reacted to a stronger-than-expected inflation reading for August. The Dow Jones Industrial Average DJIA, -2.67% dropped more than 500 points, or 1.7%, soon after the opening bell, while the S&P 500 SPX, -3.05% fell 2.2% and the technology-heavy Nasdaq Composite COMP, -3.83% dropped 2.9%, according to FactSet […]

Sep 13
Akero’s experimental NASH drug meets the primary endpoint in a clinical trial

Shares of Akero Therapeutics Inc. AKRO, +4.78% soared 101.1% in premarket trading on Tuesday after the company said its experimental treatment for nonalcoholic steatohepatitis met a primary and secondary endpoint in a Phase 2b clinical trial. NASH is a liver disease. “The magnitude and general consistency of results observed across the Phase 2a BALANCED and […]

Sep 13
Bank of America pays $5 mln fine for reporting failures in large option position trades

The Financial Industry Regulatory Authority (Finra) said it has fined Bank of America Corp.’s BAC, +0.94% BofA Securities Inc. unit a $5 Million for reporting failures in large option positions in trades from 2009 to 2020. Finfra said BofA failed to report over-the-counter options positions more than 7.4 million times, according to a statement released […]

Sep 13
OPEC leaves forecast for oil-demand growth unchanged in 2022 and 2023

The Organization of the Petroleum Exporting Countries on Tuesday left its forecast for growth in world oil demand unchanged in 2022 and 2023. In its monthly report, OPEC said oil demand remains on track for a rise of 3.1 million barrels a day in 2022, with the second quarter revised higher amid better-than-anticipated demand in […]

Sep 13
Adobe stock gets another downgrade

BMO Capital Markets analyst Keith Bachman downgraded Adobe Systems Inc. ADBE, +0.40% shares to market perform from outperform Tuesday, though he noted that his ratings change reflected the results of a broader survey on interest in the company’s Creative Cloud suite of software rather than specific concerns about the upcoming quarterly results Adobe is due […]

Sep 13
Eastman Chemical stock drops after profit outlook slashed on demand slowdown, challenging logistics

Shares of Eastman Chemical Co. EMN, +1.30% slumped 3.0% in premarket trading Tuesday, after the specialty chemicals company cut its third-quarter earnings outlook, citing a slowdown in demand and challenging logistics. The company now expects adjusted earnings per share for the quarter through September of approximately $2.00, compared with previous guidance of “solid growth” relative […]

Sep 12
VMware charged by SEC with misleading investors with sales practices

VMware Inc. VMW, +0.47% was charged by the Securities and Exchange Commission late Monday for misleading investors about its sales practices. The SEC said “beginning in fiscal year 2019, VMware began delaying the delivery of license keys on some sales orders until just after quarter-end so that it could recognize revenue from the corresponding license […]